Survey of Cancer Patients' Perceptions of Difficulties Encountered When Filling Opioid Prescriptions

M.D. Anderson Cancer Center

Status: Unknown

Conditions: Malignant Neoplasm; Pain

Treatments: Other: Survey Administration; Other: Medical Chart Review

Study type: Observational

Funder types: Other; NIH

Identifiers

NCT03989128

P30CA016672 (U.S. NIH Grant/Contract)

NCI-2019-02912 (Registry Identifier)

2019-0052 (Other Identifier)

Details and patient eligibility

About

This trial studies the problems that cancer patients face when filling prescriptions for opioids (medications that are used to manage pain). Pain is one of the most common symptoms among cancer patients. Opioid therapy is generally the treatment of choice for adequate management of cancer-related pain. Knowledge of these problems may help health care providers assess the most effective treatment options for cancer patients, and inform policy makers of the adjustments that need to be made to regulations to ensure cancer patients don't lose their access to opioids.

Full description

PRIMARY OBJECTIVES:

I. To evaluate patients' perceptions of overall difficulties when filling their opioid prescription.

SECONDARY OBJECTIVES:

I. To determine cancer patients' perceptions of financial, logistical, and psychosocial difficulties when filling their opioid prescription.

II. To evaluate the association between patient characteristics and patient difficulty filling opioid prescriptions.

OUTLINE:

Participants complete a survey over 5-10 minutes.

Enrollment: 140 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients must be on opioids provided by the Supportive Care Center (SCC), and must have visited the SCC 2 previous times for the purpose of opioid pain management. This will ensure that 1) patients will have been told that they are being prescribed an opioid as a treatment for pain, and 2) patients will have gone to a pharmacy to fill their opioid prescription a minimum of one time.
• Patients must be able to understand, read, write, and speak English.
• Patients must sign an informed consent document.
• Patients must have a cancer diagnosis.

Exclusion criteria

• Patients who have clinical evidence of cognitive impairment (Memorial Delirium Assessment Scale [MDAS] score of >= 13) as determined by the research staff, treating physician, or nurse.
• Patients who are considered to be in severe physical or emotional distress based on the assessment by the research staff.
• Patients who refuse to participate in the study.

Trial design

140 participants in 1 patient group

Observational (survey)

Description:

Participants complete a survey over 5-10 minutes

Treatment:

Other: Survey Administration

Other: Medical Chart Review